Fysicon B.V. has been acquired by Canon Medical Systems
Canon Medical Systems Corporation, a Japan-based developer of medical diagnostic imaging systems and medical solutions, has acquired Fysicon B.V., a developer of healthcare information systems in the Netherlands, for an undisclosed consideration.
Fysicon is a developer and assembler of innovative medical software and hardware for hospitals, clinics and research institutes. Since its foundation in 1996 and with unique advanced technologies and clinical evidence, Fysicon has developed and manufactured product families such as cardiovascular monitoring systems. Fysicon's CEO Linda Elberse, said: "Now we are ready to take our business to the next level, and we truly appreciate the Dutch team's role in helping to make it happen."
Canon Medical Systems Corporation develops medical diagnostic imaging systems and medical solutions. It offers angiography, computed tomography, magnetic resonance, ultrasound, X-ray, nuclear medicine, healthcare imaging informatics systems and RF amplifier components. The company was founded in 1930 and is headquartered in Otawara-shi, Japan, with subsidiaries in Japan, North America, South America, Europe, Africa, the Mid-East, Asia, and Oceania.
Oaklins' healthcare team in the Netherlands advised the selling shareholder throughout the process.
Talk to the deal team
Related deals
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn moreSLT has been acquired by Indutrade
SLT S.r.l. has been acquired by Indutrade AB and will be integrated into the group’s life science business area. The transaction is Indutrade’s fifth acquisition in 2025 and is expected to have a marginally positive impact on the group’s earnings per share.
Learn more